AI assistant
BIOGEN INC. — Director's Dealing 2010
Apr 26, 2010
30291_dirs_2010-04-26_9fad8019-af30-4054-aaf3-82920e1c71ea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-04-23
Reporting Person: Hamm Robert A (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-04-23 | Common Stock | S | 2117 | $52.1986 | Disposed | 30763.41 | Direct |
| 2010-04-23 | Common Stock | S | 2138 | $52.1996 | Disposed | 28625.41 | Direct |
| 2010-04-23 | Common Stock | S | 710 | $52.158 | Disposed | 27915.41 | Direct |
| 2010-04-23 | Common Stock | S | 703 | $52.1909 | Disposed | 27212.41 | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3: This represents the weighted average price for shares sold at a range between $52.00 (low) and $52.39 (high).
F4: This represents the weighted average price for shares sold at a range between $52.00 (low) and $52.44 (high).
F5: This represents the weighted average price for shares sold at a range between $52.01 (low) and $52.42 (high).
F6: This represents the weighted average price for shares sold at a range between $52.03 (low) and $52.4425 (high).